Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2026 Filed Mar 3, 2026 17:18 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 307 | $107.88 | $33,119.16 |
DisclosureSEC source: 0000785161-26-000095 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,694 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:14 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 369 | $107.88 | $39,807.72 |
DisclosureSEC source: 0000785161-26-000091 · form4.xml · nonDerivative · entry 1 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,644.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:17 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 280 | $107.88 | $30,206.40 |
DisclosureSEC source: 0000785161-26-000093 · form4.xml · nonDerivative · entry 1 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,262 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:12 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 416 | $107.88 | $44,878.08 |
DisclosureSEC source: 0000785161-26-000089 · form4.xml · nonDerivative · entry 1 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,947 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:10 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 2,187 | $107.88 | $235,933.56 |
DisclosureSEC source: 0000785161-26-000087 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,962 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:08 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
Tax withholdingEncompass Health Common Stock | 545 | $107.88 | $58,794.60 |
DisclosureSEC source: 0000785161-26-000085 · form4.xml · nonDerivative · entry 1 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,437 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:07 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 776 | $107.88 | $83,714.88 |
DisclosureSEC source: 0000785161-26-000083 · form4.xml · nonDerivative · entry 1 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,377 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:32 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 380 | $106.15 | $40,337.00 |
DisclosureSEC source: 0000785161-26-000075 · form4.xml · nonDerivative · entry 1 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,542 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:33 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 2,488 | $106.15 | $264,101.20 |
DisclosureSEC source: 0000785161-26-000077 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,149 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:29 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
Tax withholdingEncompass Health Common Stock | 506 | $106.15 | $53,711.90 |
DisclosureSEC source: 0000785161-26-000073 · form4.xml · nonDerivative · entry 1 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,982 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:18 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 14,818 | $106.15 | $1,572,930.70 |
DisclosureSEC source: 0000785161-26-000071 · form4.xml · nonDerivative · entry 1 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,153 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:14 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 440 | $106.15 | $46,706.00 |
DisclosureSEC source: 0000785161-26-000067 · form4.xml · nonDerivative · entry 1 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,013.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:17 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 404 | $106.15 | $42,884.60 |
DisclosureSEC source: 0000785161-26-000069 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,001 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:11 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 6,990 | $106.15 | $741,988.50 |
DisclosureSEC source: 0000785161-26-000065 · form4.xml · nonDerivative · entry 1 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,363 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:42 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 287 | $106.55 | $30,579.85 |
DisclosureSEC source: 0000785161-26-000063 · form4.xml · nonDerivative · entry 2 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,453.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 1,797 | $106.55 | $191,470.35 |
DisclosureSEC source: 0000785161-26-000061 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,637 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:39 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 208 | $106.55 | $22,162.40 |
DisclosureSEC source: 0000785161-26-000059 · form4.xml · nonDerivative · entry 2 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,922 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:37 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 228 | $106.55 | $24,293.40 |
DisclosureSEC source: 0000785161-26-000057 · form4.xml · nonDerivative · entry 2 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,405 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:36 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 328 | $106.55 | $34,948.40 |
DisclosureSEC source: 0000785161-26-000055 · form4.xml · nonDerivative · entry 2 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,353 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:34 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 674 | $106.55 | $71,814.70 |
DisclosureSEC source: 0000785161-26-000053 · form4.xml · nonDerivative · entry 2 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,971 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:33 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
Tax withholdingEncompass Health Common Stock | 405 | $106.55 | $43,152.75 |
DisclosureSEC source: 0000785161-26-000051 · form4.xml · nonDerivative · entry 2 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,488 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:47 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
GrantEncompass Health Common Stock | 1,884 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000047 · form4.xml · nonDerivative · entry 2 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,756.061 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:46 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
GrantEncompass Health Common Stock | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000045 · form4.xml · nonDerivative · entry 2 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,584 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:45 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
GrantEncompass Health Common Stock | 4,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000043 · form4.xml · nonDerivative · entry 2 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,353 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:43 UTC |
Price Andrew LChief Accounting Officer
|
GrantEncompass Health Common Stock | 1,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000041 · form4.xml · nonDerivative · entry 2 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,325 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:41 UTC |
Tarr Mark JDirector · President & CEO
|
GrantEncompass Health Common Stock | 12,796 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000039 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,812 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:38 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
GrantEncompass Health Common Stock | 3,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000035 · form4.xml · nonDerivative · entry 2 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,086 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:40 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
GrantEncompass Health Common Stock | 1,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000037 · form4.xml · nonDerivative · entry 2 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,609 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:42 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
Tax withholdingEncompass Health Common Stock | 4,016 | $107.15 | $430,314.40 |
DisclosureSEC source: 0000785161-26-000063 · form4.xml · nonDerivative · entry 1 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,740.061 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
Tax withholdingEncompass Health Common Stock | 43,378 | $107.15 | $4,647,952.70 |
DisclosureSEC source: 0000785161-26-000061 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,434 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:39 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
Tax withholdingEncompass Health Common Stock | 3,479 | $107.15 | $372,774.85 |
DisclosureSEC source: 0000785161-26-000059 · form4.xml · nonDerivative · entry 1 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,130 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:37 UTC |
Price Andrew LChief Accounting Officer
|
Tax withholdingEncompass Health Common Stock | 3,692 | $107.15 | $395,597.80 |
DisclosureSEC source: 0000785161-26-000057 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,633 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:36 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
Tax withholdingEncompass Health Common Stock | 7,903 | $107.15 | $846,806.45 |
DisclosureSEC source: 0000785161-26-000055 · form4.xml · nonDerivative · entry 1 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,681 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:34 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
Tax withholdingEncompass Health Common Stock | 16,708 | $107.15 | $1,790,262.20 |
DisclosureSEC source: 0000785161-26-000053 · form4.xml · nonDerivative · entry 1 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,645 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:33 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
Tax withholdingEncompass Health Common Stock | 3,193 | $107.15 | $342,129.95 |
DisclosureSEC source: 0000785161-26-000051 · form4.xml · nonDerivative · entry 1 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,893 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:47 UTC |
Charbonneau Elissa JoyChief Medical Officer
|
GrantEncompass Health Common Stock | 8,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000047 · form4.xml · nonDerivative · entry 1 Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,872.061 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:46 UTC |
Darby John PatrickEVP, Gen Counsel & Secretary
|
GrantEncompass Health Common Stock | 17,720 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000045 · form4.xml · nonDerivative · entry 1 Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,430 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:45 UTC |
COLTHARP DOUGLAS EEVP & Chief Financial Officer
|
GrantEncompass Health Common Stock | 37,588 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000043 · form4.xml · nonDerivative · entry 1 COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,923 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:43 UTC |
Price Andrew LChief Accounting Officer
|
GrantEncompass Health Common Stock | 8,178 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000041 · form4.xml · nonDerivative · entry 1 Price Andrew L · CIK 0001475399 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,765 F1 · shares: This issuance of restricted stock is the result of the satisfaction performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:41 UTC |
Tarr Mark JDirector · President & CEO
|
GrantEncompass Health Common Stock | 100,946 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000039 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,016 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:38 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
GrantEncompass Health Common Stock | 10,254 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000035 · form4.xml · nonDerivative · entry 1 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,296 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:40 UTC |
Fay EdmundSr. Vice Pres. and Treasurer
|
GrantEncompass Health Common Stock | 7,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000037 · form4.xml · nonDerivative · entry 1 Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,179 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 213 | $113.58 | $24,192.54 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 7 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,070 Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 87,745 | $113.09 | $9,923,082.05 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 6 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,283 F6 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.58 to $113.52, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 6,057 | $111.89 | $677,717.73 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 5 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,028 F5 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.55 to $112.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 10,954 | $110.92 | $1,215,017.68 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 4 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,085 F4 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.52 to $111.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 15,584 | $110.07 | $1,715,330.88 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,039 F3 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.52 to $110.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 13,231 | $108.80 | $1,439,532.80 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,623 F2 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.17, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC |
Tarr Mark JDirector · President & CEO
|
SaleEncompass Health Common Stock | 16,216 | $108.03 | $1,751,814.48 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,854 F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $108.45, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 10, 2026 Filed Feb 10, 2026 21:30 UTC |
Tuer Patrick WilliamEVP, Chief Operating Officer
|
SaleEncompass Health Common Stock | 2,804 | $107.62 | $301,766.48 |
DisclosureSEC source: 0000785161-26-000030 · form4.xml · nonDerivative · entry 1 Tuer Patrick William · CIK 0002065822 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,042 F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.55 to $107.73, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.